Publications

You can use the filters to show only results that match your interests

Filter publications
212 publications by Medicines and Healthcare Products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Suspended and revoked licences for manufacturers and wholesalers of medicines

  2. Field safety notices: information from medical device manufacturers

    • 27 May 2015
    • MHRA
    • Notice
  3. Annual review of good clinical practice referrals: 2011 to 2014

  4. Early access to medicines scheme applications: pending, refused, granted

    • 27 May 2015
    • MHRA
    • Statistics
  5. Parallel import licences granted in April 2015

  6. Marketing authorisations granted in April 2015

  7. Advertising investigations: March 2015

  8. Advertising investigations: February 2015

  9. Quarterly reports on the import of unlicensed medicines

    • 22 April 2015
    • MHRA
    • Statistics
  10. Clinical trials for medicines: authorisation assessment performance

    • 21 April 2015
    • MHRA
    • Transparency data
  11. Field safety notice (FSN): what it is and why it's important

    • 17 April 2015
    • MHRA
    • Guidance
  12. Parallel import licences granted in March 2015

  13. Marketing authorisations granted in March 2015

  14. Advertising investigations: January 2015

  15. Advertising investigations: December 2014

  16. Managing medical devices

  17. Veterinary medicines: application forms for manufacture or wholesale

    • 2 April 2015
    • MHRA
    • Form
  18. Medicines and Healthcare products Regulatory Agency board member expenses from July to September 2014

    • 2 April 2015
    • MHRA
    • Transparency data
  19. Medicines: company-led recalls

    • 1 April 2015
    • MHRA
    • Notice
  20. Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2014 - 2015

    • 31 March 2015
    • MHRA
    • Transparency data
  21. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2014 - 2015

    • 31 March 2015
    • MHRA
    • Transparency data
  22. Advertising investigations: November 2014

  23. Pharmacovigilance inspection metrics, 2009 to present

  24. Marketing authorisations granted in February 2015

  25. Parallel import licences granted in February 2015

  26. British Pharmacopoeia Commission: triennial review

    • 26 March 2015
    • DH and MHRA
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  27. Commission on Human Medicines: triennial review

    • 26 March 2015
    • DH, MHRA and CHM
    • Consultation outcome

    First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government

  28. Hormonal pregnancy tests: call for evidence

    • 25 March 2015
    • MHRA
    • Open consultation
  29. Register of brokers authorised to deal in human medicines

  30. Regulatory research dementia workshop conclusions

    • 16 March 2015
    • MHRA
    • Guidance
  31. Good manufacturing practice: data integrity definitions and guidance

    • 13 March 2015
    • MHRA
    • Guidance
  32. Early Access to Medicines Scheme (EAMS) scientific opinion: Pembrolizumab (MK-3475)

    • 11 March 2015
    • MHRA
    • Decision
  33. Medicines: new manufacturing and wholesale dealer licences

  34. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  35. Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)

    • 25 February 2015
    • MHRA
    • Closed consultation
  36. Medicines: licensing time-based performance measures

    • 17 February 2015
    • MHRA
    • Statistics
  37. Marketing authorisations granted in October 2014

  38. Parallel import licences granted in January 2015

  39. Marketing authorisations granted in January 2015

  40. Human and veterinary medicines: register of licensed wholesale distribution sites